HLA-A*24:02 EBV LMP-2 Tetramer-TYGPVFMCL-APC

MBL Life Sciences

Catalog No.: MBL-TC-0117-2

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

• Application: FC
• Reactivity: Human
• Conjugation: APC
• Immunogen: EBV LMP-2
• Peptide Sequence: TYGPVFMCL
• Class: Class I
• MHC Allele: A*24:02